Results for tag: "Vimpat"

Vimpat (lacosamide) is a medication used to treat partial-onset seizures in adults and children four years of age and older. It is a member of the class of drugs known as Central Nervous System (CNS) drugs, which are used to treat a variety of neurological conditions. Vimpat works by blocking sodium channels in the brain, which helps to reduce the frequency of seizures. It is available in both oral and intravenous forms. Vimpat is marketed by UCB, a biopharmaceutical company based in Belgium. It is approved for use in the United States, Europe, and other countries. In the United States, Vimpat is also approved for use as an adjunctive therapy for the treatment of partial-onset seizures in adults and children four years of age and older. Other companies in the CNS drugs market include Pfizer, GlaxoSmithKline, Merck, and Novartis. These companies produce a variety of medications used to treat neurological conditions, including epilepsy, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. Show Less Read more